Omnicell Inc (OMCL) is a publicly traded Healthcare sector company. As of October 29, 2026, OMCL trades at $35.16 with a market cap of $1.68B and a P/E ratio of 41.51. OMCL moved -2.20% today. Year to date, OMCL is -20.36%; over the trailing twelve months it is +20.07%. Its 52-week range spans $22.66 to $55.00. Analyst consensus is strong buy with an average price target of $56.00. Rallies surfaces OMCL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for OMCL shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $35.16 |
| Market Cap | $1.68B |
| P/E Ratio | 41.51 |
| EPS | $0.85 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.00 |
| 52-Week Low | $22.66 |
| Volume | 1.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.25B |
| Net Income | $39.08M |
| Gross Margin | 44.77% |
7 analysts cover OMCL: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $56.00.